{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:25:47Z","timestamp":1792167947587,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/nrendo.2009.50","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T06:39:07Z","timestamp":1242369547000},"page":"285-288","source":"Crossref","is-referenced-by-count":45,"title":["A case of severe, refractory diabetic gastroparesis managed by prolonged use of aprepitant"],"prefix":"10.1038","volume":"5","author":[{"given":"Kiang","family":"Chong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Dhatariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrendo200950_CR1","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMcp062614","volume":"356","author":"M Camilleri","year":"2007","unstructured":"Camilleri, M. Clinical practice. Diabetic gastroparesis. N. Engl. J. Med. 356, 820\u2013829 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo200950_CR2","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1023\/A:1026665728213","volume":"43","author":"I Soykan","year":"1998","unstructured":"Soykan, I., Sivri, B., Sarosiek, I., Kiernan, B. & McCallum, R. W. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig. Dis. Sci. 43, 2398\u20132404 (1998).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrendo200950_CR3","first-page":"237","volume":"56","author":"MC Kockar","year":"2002","unstructured":"Kockar, M. C., Kayahan, I. K. & Baybek, N. Diabetic gastroparesis in association with autonomic neuropathy and microvasculopathy. Acta Med. Okayama 56, 237\u2013243 (2002).","journal-title":"Acta Med. Okayama"},{"key":"BFnrendo200950_CR4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.2337\/diacare.24.7.1264","volume":"24","author":"KL Jones","year":"2001","unstructured":"Jones, K. L.  et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 24, 1264\u20131269 (2001).","journal-title":"Diabetes Care"},{"key":"BFnrendo200950_CR5","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.2337\/diacare.27.10.2341","volume":"27","author":"BE Lacy","year":"2004","unstructured":"Lacy, B. E., Crowell, M. D., Schettler-Duncan, A., Mathis, C. & Pasricha, P. J. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 27, 2341\u20132347 (2004).","journal-title":"Diabetes Care"},{"key":"BFnrendo200950_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1365-2036.1998.00289.x","volume":"12","author":"MC Edmunds","year":"1998","unstructured":"Edmunds, M. C., Chen, J. D., Soykan, I., Lin, Z. & McCallum, R. W. Effect of octreotide on gastric and small bowel motility in patients with gastroparesis. Aliment. Pharmacol. Ther. 12, 167\u2013174 (1998).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrendo200950_CR7","doi-asserted-by":"crossref","unstructured":"American Society of Clinical Oncology  et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J. Clin. Oncol. 24, 2932\u20132947 (2006).","DOI":"10.1200\/JCO.2006.06.9591"},{"key":"BFnrendo200950_CR8","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology, v.2. 2009: antiemesis \n                    http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf\n                    \n                   (2009)."},{"key":"BFnrendo200950_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2036.2008.03618.x","volume":"27","author":"JL Madsen","year":"2008","unstructured":"Madsen, J. L. & Fuglsang, S. A randomized, placebo-controlled, crossover, double-blind trial of the NK1 receptor antagonist aprepitant on gastrointestinal motor function in healthy humans. Aliment. Pharmacol. Ther. 27, 609\u2013615 (2008).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrendo200950_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1365-2036.2007.03461.x","volume":"26","author":"RW McCallum","year":"2007","unstructured":"McCallum, R. W., Cynshi, O. & Investigative Team. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis\u2014a randomized, multicentre, placebo-controlled study. Aliment. Pharmacol. Ther. 26, 1121\u20131130 (2007).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrendo200950_CR11","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/cncr.11320","volume":"97","author":"SP Chawla","year":"2008","unstructured":"Chawla, S. P.  et al. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. Cancer 97, 2290\u20132300 (2008).","journal-title":"Cancer"},{"key":"BFnrendo200950_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1056\/NEJM199901213400304","volume":"340","author":"RM Navari","year":"1999","unstructured":"Navari, R. M.  et al. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754, 030 Antiemetic Trials Group. N. Engl. J. Med. 340, 190\u2013195 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo200950_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.biopsych.2005.07.013","volume":"59","author":"M Keller","year":"2006","unstructured":"Keller, M.  et al. Lack of efficacy of the substance P (neurokinin 1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol. Psychiatry 59, 216\u2013223 (2006).","journal-title":"Biol. Psychiatry"},{"key":"BFnrendo200950_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0016-5085(03)00878-3","volume":"125","author":"T Abell","year":"2003","unstructured":"Abell, T.  et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 125, 421\u2013428 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrendo200950_CR15","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1007\/s10620-005-2782-7","volume":"50","author":"Z Lin","year":"2005","unstructured":"Lin, Z., McElhinney, C., Sarosiek, I., Forster, J. & McCallum, R. Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and\/or antiemetic medications and the need for hospitalizations. Dig. Dis. Sci. 50, 1328\u20131334 (2005).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrendo200950_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2982.2005.00732.x","volume":"18","author":"Z Lin","year":"2007","unstructured":"Lin, Z., Sarosiek, I., Forster, J. & McCallum, R. W. Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol. Motil. 18, 18\u201327 (2007).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrendo200950_CR17","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2004.09.055","volume":"127","author":"HP Parkman","year":"2004","unstructured":"Parkman, H. P.  et al. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 127, 1592\u20131622 (2004).","journal-title":"Gastroenterology"}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.50","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrendo.2009.50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:33:13Z","timestamp":1684467193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2009.50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFnrendo200950"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2009.50","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}